Latest California Healthline Stories
New, often lower-cost plans capitalize on the convenience of telemedicine — and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.
Long-term relationships between patients and doctors often enrich the quality of care and create deep emotional bonds. When the doctors retire or move on, saying goodbye can be hard.
Patients are caught in the middle as insurers clamp down on paying for treatments or force prior authorizations for care.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.
Televisits took off during the worst days of the pandemic, but states are now rolling back the temporary rules that facilitated them. That’s adding fuel to debates about states’ authority over medical licensing.
Abigail Matos-Pagán, a critical care expert who has galvanized relief efforts after hurricanes and earthquakes, is on a mission to inoculate as many Puerto Rican residents as possible.
Abigail Matos-Pagán, experta en cuidados críticos que ha impulsado tareas de ayuda tras huracanes y terremotos, se ha propuesto vacunar al mayor número posible de residentes de Puerto Rico.
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.